A European approach to clinical investigator training.
A better education and training of clinical investigators and their teams is one of the factors that could foster the development of clinical research in Europe, a key objective of the Innovative Medicines Initiative (IMI). PharmaTrain (an IMI programme on training in medicines development), and European Clinical Research Infrastructures Network (ECRIN) have joined forces to address this issue. An advisory group composed of representatives of universities, pharmaceutical companies and other organisations met four times between June 2011 and July 2012. This resulted in a position paper proposing a strategy to improve and harmonize clinical investigator training in Europe, and including a detailed syllabus and list of learning outcomes. Major recommendations are the establishment of minimal and mutually recognized certification requirement for investigators throughout the EU and the creation of a European platform to provide a suitable course and examination infrastructure.
Erasme Hospital, PHARMED, Université Libre de Bruxelles Brussels, Belgium.
Jean-Marie
JM
Boeynaems
Cindy
C
Canivet
Anthony
A
Chan
Mary J
MJ
Clarke
Catherine
C
Cornu
Esther
E
Daemen
Jacques
J
Demotes
Katelijne De
KD
Nys
Barry
B
Hirst
Ferdinand
F
Hundt
Behrouz
B
Kassai
Sandor
S
Kerpel-Fronius
Lucy
L
Kiessig
Heinrich
H
Klech
Jean-Pierre
JP
Kraehenbuhl
Pierre
P
Lafolie
Martin
M
Lucht
Detlef
D
Niese
Christiane
C
Pauli-Magnus
Barbara
B
Peters
Ralf
R
Schaltenbrand
Armel
A
Stockis
Martina
M
Stykova
Nicolette
N
Verheus
Ingrid
I
Klingmann
GCP; certification; clinical investigator; clinical trials as topic; training